Supreme Court Upholds High Court Decision on Objections in Bulk Drug Manufacturing Case The Supreme Court dismissed the appeals against the High Court judgment, which held that objections should be raised before the issuing authority first in ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Supreme Court Upholds High Court Decision on Objections in Bulk Drug Manufacturing Case
The Supreme Court dismissed the appeals against the High Court judgment, which held that objections should be raised before the issuing authority first in a case involving a bulk drug manufacturer using platinum catalyst. The Court found the writ petition against the show cause notice premature and upheld the High Court's decision. No costs were awarded.
The Supreme Court dismissed the appeals against the High Court judgment dated 5th November 1997. The case involved a bulk drug manufacturer using platinum catalyst, which the Department claimed amounted to manufacture when regenerated. The High Court held that objections should be raised before the issuing authority first. The Court upheld the High Court's decision, stating that the writ petition against the show cause notice was premature. The appeals were dismissed, and no costs were awarded.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
